These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8607105)

  • 1. Low prevalence of the factor V Leiden mutation among "severe" hemophiliacs with a "milder" bleeding diathesis.
    Arbini AA; Mannucci PM; Bauer KA
    Thromb Haemost; 1995 Nov; 74(5):1255-8. PubMed ID: 8607105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia A.
    Lee DH; Walker IR; Teitel J; Poon MC; Ritchie B; Akabutu J; Sinclair GD; Pai M; Wu JW; Reddy S; Carter C; Growe G; Lillicrap D; Lam M; Blajchman MA
    Thromb Haemost; 2000 Mar; 83(3):387-91. PubMed ID: 10744141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V Leiden and hemophilia.
    Franchini M; Lippi G
    Thromb Res; 2010 Feb; 125(2):119-23. PubMed ID: 19932655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of prothrombotic mutations on factor consumption in adult patients with severe hemophilia.
    Ar MC; Baykara O; Buyru AN; Baslar Z
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):660-5. PubMed ID: 18603540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding symptoms in carriers of hemophilia A and B.
    Mauser Bunschoten EP; van Houwelingen JC; Sjamsoedin Visser EJ; van Dijken PJ; Kok AJ; Sixma JJ
    Thromb Haemost; 1988 Jun; 59(3):349-52. PubMed ID: 2847347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
    Orstavik KH; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 2000 Mar; 83(3):433-7. PubMed ID: 10744150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
    Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
    Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro analysis of the combination of hemophilia A and factor V(LEIDEN).
    van 't Veer C; Golden NJ; Kalafatis M; Simioni P; Bertina RM; Mann KG
    Blood; 1997 Oct; 90(8):3067-72. PubMed ID: 9376587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phenotypic heterogeneity of severe hemophilia.
    Jayandharan GR; Srivastava A
    Semin Thromb Hemost; 2008 Feb; 34(1):128-41. PubMed ID: 18393149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genotyping of the Italian cohort of patients with hemophilia B.
    Belvini D; Salviato R; Radossi P; Pierobon F; Mori P; Castaldo G; Tagariello G;
    Haematologica; 2005 May; 90(5):635-42. PubMed ID: 15921378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
    El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
    Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of natural anticoagulant and fibrinolytic factors in modulating the clinical severity of haemophilia patients.
    Shetty S; Vora S; Kulkarni B; Mota L; Vijapurkar M; Quadros L; Ghosh K
    Br J Haematol; 2007 Aug; 138(4):541-4. PubMed ID: 17659055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
    Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Double mutation, a 2-bp deletion and Val211Ile, in the blood coagulation factor IX gene of a patient with severe hemophilia B].
    Seita I; Shinozawa K; Otaki M; Fujita S; Suzuki T; Amano K; Inaba H; Fukutake K
    Rinsho Byori; 2009 May; 57(5):417-24. PubMed ID: 19522246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
    Libourel EJ; Bank I; Meinardi JR; Baljé -Volkers CP; Hamulyak K; Middeldorp S; Koopman MM; van Pampus EC; Prins MH; Büller HR; van der Meer J
    Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience of a single Italian center in genetic counseling for hemophilia: from linkage analysis to molecular diagnosis.
    Tagariello G; Belvini D; Salviato R; Are A; De Biasi E; Goodeve A; Davoli P
    Haematologica; 2000 May; 85(5):525-9. PubMed ID: 10800171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden mutation and type 1 diabetes mellitus.
    Demirer AN; Alikasifoglu M; Tuncbilek E; Karakus S; Erbas T
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):70-4. PubMed ID: 18180619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile.
    Santagostino E; Mancuso ME; Tripodi A; Chantarangkul V; Clerici M; Garagiola I; Mannucci PM
    J Thromb Haemost; 2010 Apr; 8(4):737-43. PubMed ID: 20102490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of hereditary coagulation factor deficiencies in eastern province, Saudi Arabia.
    Islam SI; Quadri MI
    East Mediterr Health J; 1999 Nov; 5(6):1188-95. PubMed ID: 11924110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.